Brief: Traws Pharma - Enters Stock Purchase Agreement With Roth Principal Investments On Oct 23, 2026 - SEC Filing
23/10/2026 23:22
BRIEF-Traws Pharma - Enters Stock Purchase Agreement With Roth Principal Investments On Oct 23, 2026 - SEC Filing Oct 23 (Reuters) - Traws Pharma Inc TRAW.O:
TRAWS PHARMA - ENTERS STOCK PURCHASE AGREEMENT WITH ROTH PRINCIPAL INVESTMENTS ON OCT 23, 2026 - SEC FILING
TRAWS PHARMA - MAY SELL UP TO $50 MILLION IN COMMON STOCK TO ROTH PRINCIPAL INVESTMENTS - SEC FILING
Source text: [ID:n0001104659-26-118519]
Further company coverage: TRAW.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Traws Pharma
See all newsBrief: Traws Pharma - Enters Stock Purchase Agreement With Roth Principal Investments On Oct 23, 2026 - SEC Filing
Traws Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Traws Pharma Q2 revenue falls to zero on licensing termination; net loss widens
Traws Pharma Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Traws Pharma Provides Updated Guidance On Influenza Prophylaxis Program